Close Menu

NEW YORK – Saladax Biomedical announced on Tuesday that five of its MyCare Psychiatry Laboratory Assays received approval from Health Canada for use in patients prescribed six antipsychotic drugs.

The tests monitor patients' blood concentration levels of prescribed drugs, including clozapine, risperidone, paliperidone, aripiprazole, olanzapine, and quetiapine, the company said in a statement. The tests run on chemistry analyzers "already present in most clinical laboratories" and results are available within hours, Bethlehem, Pennsylvania-based Saladax said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.